PRETREATMENT PLASMA-LEVELS OF FIBRINOPEPTIDE-A (FPA), D-DIMER (DD), AND VON-WILLEBRAND FACTOR (VWF) IN PATIENTS WITH OPERABLE CERVICAL-CANCER - INFLUENCE OF SURGICAL PATHOLOGICAL STAGE, TUMOR SIZE, HISTOLOGIC TYPE, AND LYMPH-NODE STATUS

被引:46
作者
GADDUCCI, A [1 ]
BAICCHI, U [1 ]
MARRAI, R [1 ]
FACCHINI, V [1 ]
DELBRAVO, B [1 ]
FOSELLA, PV [1 ]
FIORETTI, P [1 ]
机构
[1] SANTA CHIARA HOSP,BLOOD BANK,PISA,ITALY
关键词
D O I
10.1006/gyno.1993.1139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The preoperative plasma levels of fibrinopeptide A (FPA), D-dimer (DD), and von Willebrand Factor (vWF) were measured in 38 patients with cervical cancer undergoing radical hysterectomy with pelvic lymphadenectomy. The surgical-pathological stage of disease was Ib in 17 patients, IIa in 9 patients, and IIb in 12 patients. The tumor size was ≤4 cm in 20 patients and >4 cm in 18 patients. The histologic type was squamous cell carcinoma in 32 patients and adenocarcinoma in 6 patients. Positive pelvic lymph nodes were found in 10 patients. When compared to controls, FPA, DD, and vWF levels were significantly raised in patients with surgical-pathological stage IIb disease but not in patients with stage Ib or IIa disease. The values of FPA, DD, and vWF were related to surgical-pathological stage (stage IIb vs stage Ib-IIa: P < 0.005, P < 0.001, and P < 0.001, respectively) and tumor size (>4 cm vs ≤4 ≤cm: P < 0.05, P < 0.005, and P < 0.02, respectively), but not to histologic type. vWF values were also related to lymph node status (positive vs negative lymph nodes: P < 0.02). FPA and DD levels were higher in patients with positive lymph nodes than in patients with negative lymph nodes, but the difference did not reach the statistical significance even due to the small number of patients involved. In conclusion, increased fibrin production and degradation seem to occur in patients with stage IIb cervical cancer. The biological meaning of this hemostasis activation deserves further investigation. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 57 条
  • [1] TISSUE PLASMINOGEN-ACTIVATOR - CHEMICAL AND PHYSIOLOGICAL-ASPECTS
    BACHMANN, F
    KRUITHOF, IEKO
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (01) : 6 - 17
  • [2] BAUER KA, 1987, BLOOD, V70, P343
  • [3] BONA RD, 1989, ANN CLIN LAB SCI, V19, P184
  • [4] BONEU B, 1975, LANCET, V1, P1430
  • [5] ANALYSIS OF FACTORS CONTRIBUTING TO TREATMENT FAILURES IN STAGE-IB AND STAGE-II-A CARCINOMA OF THE CERVIX
    CHUNG, CK
    NAHHAS, WA
    STRYKER, JA
    CURRY, SL
    ABT, AB
    MORTEL, R
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 138 (05) : 550 - 556
  • [6] FIBRINOPEPTIDE-A IN PLASMA OF NORMAL SUBJECTS AND PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    CRONLUND, M
    HARDIN, J
    BURTON, J
    LEE, L
    HABER, E
    BLOCH, KJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (01) : 142 - 151
  • [7] DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
  • [8] DVORAK HF, 1981, LYMPHOKINE REP, V2, P203
  • [9] ABNORMALITIES OF BLOOD-COAGULATION TESTS IN PATIENTS WITH CANCER
    EDWARDS, RL
    RICKLES, FR
    MORITZ, TE
    HENDERSON, WG
    ZACHARSKI, LR
    FORMAN, WB
    CORNELL, CJ
    FORCIER, RJ
    ODONNELL, JF
    HEADLEY, E
    KIM, SH
    ODELL, R
    TORNYOS, K
    KWAAN, HC
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 88 (05) : 596 - 602
  • [10] FACCHINI V, 1988, European Journal of Gynaecological Oncology, V9, P87